Otmar RM Wikkeling, MD, MBA, CMIO is a vascular surgeon with a special interest in lymphedema and deep venous diseases. As one of the founding fathers of one of the four specialized centers in this pathology in the Netherlands, this subject is very dear to him and his other specialty is data-driven care.
Abstract
DVT in pregnancy is a real world problem, which is a highly underestimated calamity. In 2018 the American Society of Hematology published guidelines “venous thromboembolism (TED) in the context of pregnancy”
•Venous TED is one of the major causes of direct maternal deaths. Those who survive suffer significant morbidity
•Pregnancy is a known hyper-coagulable state, with a five-fold risk of venous thromboembolism over the non-pregnant condition
•0.5 - 3 of every 1000 pregnancies are complicated by symptomatic deep venous thrombosis (DVT).
•Cesarean delivery > vaginal delivery
•75% of DVT occur antepartum (equally distributed among all three trimesters)
•DVT is far more common in the left than the right leg
•Mortality rate as high as 15% (!)
•25% may develop pulmonary embolism (PE),
•40 - 60% of Pulmonary Embolism (PE) occur after delivery
•PE is the major non-obstetric cause of maternal mortality
–2/100,000 pregnancies2
In this talk we will cover all aspects, from incidence, pathophysiology, diagnostics , treatment and management options, special procedures and complications.